Movement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating

Market Focus

07/10

On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.

On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.

Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1105880809"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105880809\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105880809?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 10:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105880809","market":"us","top_or_hot":-1,"title":"Movement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating","media":"Market Focus","content":"<p><p>On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.</p><p>On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.</p><p>Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JD Health Rises 3.23% in Regular Trading, Internet Healthcare Sector Broadly Strengthens as UBS Maintains Buy Rating\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time smaller\">2026-07-10 10:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><p>On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.</p><p>On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.</p><p>Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京東健康","start_time":0,"source_url":"","article_id":"1105880809","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105880809","pubTimestamp":1783649686,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.On the news front, the Internet & Direct Marketing Retail sector...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"走势提醒|京东健康常规交易上涨3.23%，瑞银维持买入评级，互联网医疗板块普遍走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"On July 10, JD Health rose 3.23% in regular trading, trading at 37.76 HKD/share, with turnover of approximately 64.18 million HKD.On the news front, the Internet & Direct Marketing Retail sector broadly strengthened, with positive industry sentiment lifting JD Health in tandem. Among sector peers, BABA-W rose 4.35%, PA Good Doctor rose 4.20%, ALI Health rose 2.94%, and JD-SW rose 2.88%.Additionally, UBS recently maintained its Buy rating on JD Health, noting the company has established competitive advantages at both the user and supply chain levels on its online platform. The bank expects the online pharmacy platform revenue to achieve a double-digit compound annual growth rate, while also noting that regulatory tightening will have limited impact on online drug purchasing behavior. UBS simultaneously maintained a Sell rating on Ali Health and lowered its target price from 3.6 HKD to 3.1 HKD, underscoring a differentiated outlook favoring JD Health within the sector.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}